DV
Dividend Vision

HBIO — Harvard Bioscience Inc

Harvard Bioscience Inc (HBIO)

Total return is -91.6% over the past 25.7 years, 911.8 points behind SPY at 820.2%. Its deepest 1-year drawdown was 45.2%.

Harvard Bioscience Inc is an equity stock focused on the life sciences and biotechnology sector. The company operates without a stated dividend distribution rate, making it primarily suited for growth-oriented investors rather than those seeking regular income. With an inception date of 2000, the company has established operations in the specialized biotech equipment and services space.

HBIO key facts

Asset type
Stock
Asset class
Equity
Inception date
12/07/2000
Last close
$6.66
Market cap
$28,098,434
Average volume
15416.0
Beta
1.495
Payout ratio
0.0
Forward P/E
15.0602
EPS
$-2.15